The main accepted tumour ablation mechanism of everolimus is the dephosphorylation of S6K1 and 4EBP1 by inhibiting mTORC1, which results in cell apoptosis, G1/S cell cycle arrest, and angiogenesis suppression37, 38, 39, 40. The gene discussed is EIF4EBP1; the disease is neoplasm.